Ex Vivo Expanded Murine Mesenchymal Stem Cells as Targets for the Generation of a Cell Replacement Therapy for Type 1 Diabetes

Field	Value	Language
dc.contributor.author	Gerace, D https://orcid.org/0000-0001-9154-0624	en_US
dc.contributor.author	Martiniello-Wilks, R https://orcid.org/0000-0002-0038-3430	en_US
dc.contributor.author	Nassif, NT https://orcid.org/0000-0003-2675-8322	en_US
dc.contributor.author	Ren, B	en_US
dc.contributor.author	Simpson, AM https://orcid.org/0000-0002-2249-5097	en_US
dc.date	2017-06-09	en_US
dc.date.issued	2017-06-01	en_US
dc.identifier.citation	DIABETES, 2017, 66 pp. A83 - A83 (1)	en_US
dc.identifier.issn	0012-1797	en_US
dc.identifier.uri	http://hdl.handle.net/10453/126625
dc.publisher	AMER DIABETES ASSOC	en_US
dc.relation.ispartof	DIABETES	en_US
dc.relation.ispartof	77th Scientific Sessions of the American-Diabetes-Association	en_US
dc.subject.classification	Endocrinology & Metabolism	en_US
dc.title	Ex Vivo Expanded Murine Mesenchymal Stem Cells as Targets for the Generation of a Cell Replacement Therapy for Type 1 Diabetes	en_US
dc.type	Conference Proceeding
utslib.citation.volume	66	en_US
utslib.location.activity	San Diego, CA	en_US
utslib.for	11 Medical and Health Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Life Sciences
pubs.organisational-group	/University of Technology Sydney/Strength - CHT - Health Technologies
utslib.copyright.status	open_access
pubs.finish-date	2017-06-13	en_US
pubs.publication-status	Published	en_US
pubs.start-date	2017-06-09	en_US
pubs.volume	66	en_US

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/126625